<DOC>
	<DOCNO>NCT01289002</DOCNO>
	<brief_summary>The purpose registry capture clinical data BioMatrix™ BioMatrix Flex™ ( Biolimus A9™-Eluting ) stent system relation safety effectiveness .</brief_summary>
	<brief_title>e-BioMatrix PostMarket Registry</brief_title>
	<detailed_description>Prospective , multi-center registry conduct 60-70 international interventional cardiology center . All patient follow 3 year .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>1 . Age ≥18 year 2 . Patients need treatment either BioMatrix™ BioMatrix Flex™ drugeluting stent 3 . Presence one coronary artery stenosis native coronary artery saphenous bypass graft 2.25 4.0 mm diameter cover one multiple stents 4 . No limitation number treat lesion , vessel , lesion length 1 . Inability provide inform consent 2 . Patients need additional stent NOT Biolimus A9™eluting stent type 3 . Patients receive next Biolimus A9™eluting stent also coronary vascular intervention , example dilation 4 . Patients receive BioMatrix™ BioMatrix Flex™ stent index and/or stag procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>